Helen M. Thackray
2014 - GlycoMimetics
In 2014, Helen M. Thackray earned a total compensation of $1.1M as Chief Medical Officer at GlycoMimetics, a 187% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $90,694 |
|---|---|
| Option Awards | $690,802 |
| Salary | $345,005 |
| Total | $1,126,501 |
Thackray received $690.8K in option awards, accounting for 61% of the total pay in 2014.
Thackray also received $90.7K in non-equity incentive plan and $345K in salary.
Rankings
In 2014, Helen M. Thackray's compensation ranked 7,058th out of 13,032 executives tracked by ExecPay. In other words, Thackray earned more than 45.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,058 out of 13,032 | 46th |
Division Manufacturing | 2,595 out of 4,966 | 48th |
Major group Chemicals And Allied Products | 882 out of 1,686 | 48th |
Industry group Drugs | 695 out of 1,365 | 49th |
Industry Pharmaceutical Preparations | 532 out of 1,043 | 49th |
Source: SEC filing on April 11, 2016.
Thackray's colleagues
We found three more compensation records of executives who worked with Helen M. Thackray at GlycoMimetics in 2014.